Avrobio's (AVRO) ARV-RD-04 Phase 1/2 Provide Proof-of-Concept, Represent a Free Call Option on Stock - Mizuho Securities

February 9, 2022 5:16 PM EST Send to a Friend
Mizuho Securities analyst Uy Ear reiterated a Buy rating and $6.00 price target on Avrobio Inc. (NASDAQ: AVRO), following a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login